Navigation Links
MedImmune's Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
Date:8/23/2007

Native American infants, with an overall incidence and severity of adverse events (AEs) that were similar between the motavizumab and the placebo groups. The mortality rates were not statistically different between groups (0.4 percent in the placebo arm, n=2 and 0.3 percent in the motavizumab arm, n=3) and were not considered to be related to the study drug. As was suggested in the pivotal Phase 3 trial conducted in high-risk, preterm infants, rates of hypersensitivity related skin rashes within two days of dosing were seen in about one percent of treated children in the motavizumab group.

MedImmune's Commitment to RSV Prevention

MedImmune is a world leader in the development of innovative therapeutic biologic products to prevent RSV disease. In 1996, MedImmune launched the first anti-RSV drug, RespiGam(R) (respiratory syncytial virus immune globulin intravenous (human) (RSV-IGIV)), which was a polyclonal antibody administered via four-hour intravenous infusion. In 1998, MedImmune introduced Synagis, which was a significant product improvement as a monthly intramuscular injection for the prevention of severe RSV, as well as being the first MAb to receive U.S. Food and Drug Administration (FDA) approval for an infectious disease. With the development of motavizumab, MedImmune continues to reinforce its commitment to developing anti-RSV products. In a head-to-head comparative Phase 3 trial with Synagis, motavizumab met its primary endpoint of reducing RSV-related hospitalizations in high-risk pediatric patients and met its secondary endpoint of reducing medically attended, outpatient respiratory tract infections in that patient group. MedImmune is also developing a small-molecule product candidate to prevent RSV as well as a vaccine against RSV, both of which are in Phase 1 clinical trials.

About RSV

Each year, up to 125,000 infants in the U.S. are hospitalized with severe RSV infections, the leading cause of lower respiratory tract infections
'/>"/>

SOURCE MedImmune, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
2. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
3. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
4. Lipitor Reduced the Risk of Coronary Events by Half and Stroke by Nearly One-Third in High-Risk Patients with Type 2 Diabetes Who Experienced a Recent Stroke
5. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
6. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
7. New Analysis of WHI Data Shows Reduced Levels of Coronary Artery Calcification, a Predictor of Cardiovascular Events, in Women aged 50-59 taking Estrogen Therapy
8. Pivotal Phase III Trial Showed Promacta (eltrombopag olamine) Raised Platelet Counts and Reduced Bleeding in Patients With Chronic ITP
9. Preclinical Study Finds Protease Inhibitor-Resistant HIV May Have Reduced Potential to Develop Resistance to Panacos Bevirimat
10. New Analysis of Data Shows Treatment With Abbotts Humira (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohns Disease
11. Data Suggest Cymbalta Reduced Severity of Night Pain in Patients with Diabetic Nerve Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... ORLANDO, Fla. , July 28, 2014 /PRNewswire/ ... "Company"), a biopharmaceutical company focused on the development, ... that it has filed definitive proxy materials with ... its 2014 Annual Meeting of Shareholders to be ... a.m., East Standard Time. The record date for ...
(Date:7/28/2014)... 2014 ResMed (NYSE: RMD ), ... cura dei disturbi respiratori del sonno (SDB) e altre ... in Germania contro il produttore Taiwanese di dispositivi medicali, ... apparecchiature da indossare in testa, che violano i brevetti, ... La sentenza della Corte Regionale Distrettuale di ...
(Date:7/28/2014)... (NYSE: RMD ), an innovator and pioneer ... and other chronic respiratory conditions, has won a permanent ... medical device manufacturer APEX Medical Corp. (APEX), prohibiting sales ... 220 masks.  The judgment was entered by the Regional ... appealable, and applies throughout Germany.  The ...
Breaking Medicine Technology:TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 2TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 3ResMed riceve un'ingiunzione permanente contro APEX in Germania, continua a far valere i propri diritti per i brevetti in Europa 2ResMed Receives Permanent Injunction against APEX in Germany, Continues Enforcement of Patents in Europe 2
(Date:7/29/2014)... In his latest blog post at http://www.perwickstrom.com , entrepreneur, ... listed 6 ways to light the “fire” in employees. , ... but for some it’s a losing battle,” commented Per ... to help employees get to the next level; which not ... According to Per Wickstrom, 6 ways to light the “fire” ...
(Date:7/29/2014)... A Forever Recovery , an open-ended drug and ... start and gives them a solid foundation in recovery they ... Cherry Festival kickoff concert held on July 5, 2014 in ... Miller Lite and in partnership with WKLT Radio, saw special ... Stage presented by Blue Cross Blue Shield and rock the ...
(Date:7/29/2014)... 29, 2014 Launched in 2012 by ... surpassed 20,000 hangovers earlier this year at its Vegas ... expansion and the publication of research data related to ... practice. , The only licensed medical practice dedicated to ... launched in 2012 and treated thousands of patients within ...
(Date:7/29/2014)... Recently, Stwd.co.uk, a distinguished online supplier of special occasion ... . As a summer special offer, all these new items ... off. All new and old customers can enjoy the huge ... announce the new evening outfits. They want to bring huge ... to launch the big sale. Our cheap evening dresses are ...
(Date:7/29/2014)... Marietta, GA (PRWEB) July 29, 2014 The ... are offering professional teeth whitening for high school ... of August 2014. The teeth whitening is a safe, ... smile leads to better confidence for students at these important ... process of braces, but have never had their teeth whitened. ...
Breaking Medicine News(10 mins):Health News:Per Wickstrom’s Latest Blog Post Lists 6 Ways to Light the “Fire” in Employees 2Health News:A Forever Recovery Sponsors National Cherry Festival Kickoff Concert Featuring Collective Soul on July 5 in Traverse City, MI 2Health News:Hangover Heaven Surpasses 20,000 Hangovers 2Health News:Hangover Heaven Surpasses 20,000 Hangovers 3Health News:Cheap Prom Dresses Available At Popular Online Store Stwd.co.uk 2Health News:Back to School Teeth Whitening Extravaganza For High School Students and Collegiates During August 2014 2Health News:Back to School Teeth Whitening Extravaganza For High School Students and Collegiates During August 2014 3
... BEIJING, June 10 /PRNewswire-Asia/ -- Sinovac Biotech Ltd.,(NYSE ... of vaccines in China,announced today that it will hold its ... a.m. Beijing Time. The meeting will be held concurrently,at No. ... No. 6 Temple,Street, St. John,s, Antigua. All shareholders of record ...
... Velocity provides robust, flexible and easy-to-use search platform to ... regulation , , PITTSBURGH, June 10 Vivisimo ... search, today announced that HCPro, a provider of education ... selected Vivisimo,s award-winning Velocity platform ...
... VEGAS, June 10 SmallCapSentinel.com announces the availability of ... related to the medical device industry featuring SenoRx, Inc. ... Inc. (NasdaqGM: STXS), ev3 Inc. (NasdaqGS: EVVV), AngioDynamics Inc. ... (NasdaqGM: CPTS). , , To read the article ...
... , , Assumes New Leadership Post At Global Health Communications, ... communications and public affairs firm Spectrum named Katherine J. Maynard as ... 11-year track record of nothing less than success at Spectrum has ... said President and CEO John J. Seng, the firm,s founder. "As ...
... Microsoft,s ,Browser for the Better, campaign donates equivalent of eight ... , REDMOND, Wash., June 10 More than 17 ... and lunch at their local public schools; as schools close ... In response, Microsoft Corp. and Feeding America are joining forces ...
... , Expectant Mothers Should Consider Visiting a Dentist During ... First Birthday , , CHICAGO, June 10 ... leader in pediatric oral health, announced new oral health ... Annual Session in Honolulu, Hawaii. The guidelines call for ...
Cached Medicine News:Health News:Sinovac Schedules 2008 Annual General Meeting 2Health News:HCPro Selects Vivisimo Velocity to Launch MedicareFind.com 2Health News:HCPro Selects Vivisimo Velocity to Launch MedicareFind.com 3Health News:SmallCapSentinel.com Releases Report for Investors of Medical Device Companies SENO, STXS, EVVV, ANGO, THOR, and CPTS 2Health News:Spectrum Names Katherine Maynard Chief Operating Officer 2Health News:Microsoft and Feeding America Join Forces to Fight Hunger 2Health News:Microsoft and Feeding America Join Forces to Fight Hunger 3Health News:American Academy of Pediatric Dentistry Releases New Perinatal and Infant Oral Health Guidelines 2Health News:American Academy of Pediatric Dentistry Releases New Perinatal and Infant Oral Health Guidelines 3Health News:American Academy of Pediatric Dentistry Releases New Perinatal and Infant Oral Health Guidelines 4
... advanced motorized inverted microscope from Olympus. , ... provides 9 access ports for multiple input ... can have simultaneous access to a primary ... 6-position nosepiece and light path selector, the ...
... Designed to provide exceptional performance ... SteREO Lumar has unrivaled fluorescence ... light microscopy instruments. Developed for ... SteREO Lumar offers first-class optical ...
... TIRF slider, which allows laser coupling via ... for observing rapid membrane processes even ... times extremely short. The easy ... and the effective laser safety equipment of ...
... The MicroFire is a 2-megapixel, 12-bit FireWire digital camera. ... be acquired effortlessly. Imaging has never been this easy! ... CCD - 2/3" Color ... Time - 500 microseconds - 60 seconds ...
Medicine Products: